On Sep 28, major Wall Street analysts update their ratings for $Accenture (ACN.US)$, with price targets ranging from $360 to $415.
UBS analyst Kevin Mcveigh maintains with a buy rating, and adjusts the target price from $400 to $415.
Guggenheim analyst Jonathan Lee CFA maintains with a buy rating.
Mizuho Securities analyst Dan Dolev maintains with a buy rating, and maintains the target price at $365.
SIG analyst James Friedman maintains with a hold rating, and adjusts the target price from $350 to $360.
Furthermore, according to the comprehensive report, the opinions of $Accenture (ACN.US)$'s main analysts recently are as follows:
The stock is anticipated to experience an expansion in its multiple as General AI is expected to drive revenue growth in conjunction with sustained capital return.
The key insights from Accenture's earnings discussion indicated that the upper limit of their FY25 constant currency revenue growth forecast, ranging from 3% to 6%, does not rely on an uptick in discretionary spending. Conversely, the lower end of the guidance is designed to withstand potential declines. The conservative nature of this early FY25 projection is thought to resonate well with investors, bolstered by a greater quantity of significant transformational agreements in the current backlog compared to the previous year.
The ongoing momentum within the Health & Public Service sector has bolstered management's belief in achieving the upper spectrum of the company's annual constant currency organic growth projection, which ranges from 0-3%. This has resulted in commentary regarding the fiscal year 2025 organic growth that is more optimistic than initially anticipated.
Accenture's recent quarter showed satisfactory performance with a 24% increase in bookings, marking the most favorable comparison in several years. The company's forecast of 3%-6% growth is considered an appropriate initial estimate. Historically, Accenture has shown variability in achieving the mid-point of its guidance. It's suggested that the results may align with the forecasted range, with potential for higher outcomes.
Accenture's robust Q4 earnings surpassed expectations, bolstered by the recognition of revenue from larger projects initiated in prior periods. This has led to a significant quarter-over-quarter advancement, most notably within its Strategy & Consulting segment. Additionally, Accenture's FY24 gen-AI bookings have exceeded $3B with revenue reaching $900M, a sharp increase from $300M in bookings and $100M in revenue reported in FY23.
Here are the latest investment ratings and price targets for $Accenture (ACN.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
